Search Results - "Fevzi Ozkaynak, Mehmet"

Favorable outcome of primary CNS anaplastic large cell lymphoma in an immunocompetent patient by Ozkaynak, Mehmet Fevzi

“…A 9-year-old immunocompetent male patient with primary central nervous system anaplastic large cell lymphoma was treated with 5 cycles of intensive…”
Get full text

Rituximab Therapy to Prevent Relapse in Chronic Relapsing Thrombotic Thrombocytopenic Purpura (TTP) in a Child by Jayabose, Somasundaram, Dunbar, Julie, Nowicki, Theodore S., Tugal, Oya, Ozkaynak, Mehmet Fevzi, Sandoval, Claudio

“…Our patient first developed thrombotic thrombocytopenic purpura (TTP) at age 10 years with an initial platelet count of 10,000/μL. She achieved remission with…”
Get full text

Cleft palate, bilateral external auditory canal atresia, and other midline defects associated with Diamond-Blackfan anemia: case report by McFarren, Alicia, Jayabose, Somasundaram, Fevzi Ozkaynak, Mehmet, Tugal, Oya, Sandoval, Claudio

“…Diamond-Blackfan anemia (DBA) is associated with congenital anomalies especially of the midline. When present, facial anomalies are reminiscent of…”
Get full text

Gemistocytic Astrocytoma With PNET Tumor Arising Within a Mature Ovarian Teratoma and Seeding Metastasis in a Premenarchal Girl by Fraiser, Candice, MD, Regard, Monique, MD, Ozkaynak, Mehmet Fevzi, MD, Davis, Mary Margaret, MD, MSc

Get full text

Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group by Desai, Ami V, Gilman, Andrew L, Ozkaynak, Mehmet Fevzi, Naranjo, Arlene, London, Wendy B, Tenney, Sheena C, Diccianni, Mitchell, Hank, Jacquelyn A, Parisi, Marguerite T, Shulkin, Barry L, Smith, Malcolm, Moscow, Jeffrey A, Shimada, Hiroyuki, Matthay, Katherine K, Cohn, Susan L, Maris, John M, Bagatell, Rochelle, Sondel, Paul M, Park, Julie R, Yu, Alice L

“…Postconsolidation immunotherapy including dinutuximab, granulocyte-macrophage colony-stimulating factor, and interleukin-2 improved outcomes for patients with…”
Get full text

Outcomes and toxicities in patients (pts) non-randomly assigned to immunotherapy Children’s Oncology Group (COG) ANBL0032 by Desai, Ami Vijay, Gilman, Andrew, Ozkaynak, Mehmet Fevzi, Naranjo, Arlene, London, Wendy B, Tenney, Sheena Cretella, Smith, Malcolm, Seibel, Nita, Shimada, Hiroyuki, Matthay, Katherine K., Cohn, Susan Lerner, Maris, John M., Bagatell, Rochelle, Sondel, Paul M., Park, Julie R., Yu, Alice L.

“…Abstract only 10523 Background: Immunotherapy with the anti-GD2 antibody dinutuximab plus sargramostim (GM-CSF), aldesleukin (IL-2) and isotretinoin following…”
Get full text

Laparoscopic Surgery for Acute Appendicitis in Children With Cancer by Singer, Julia, Stringel, Gustavo, Ozkaynak, Mehmet Fevzi, McBride, Whitney, Pandya, Samir, Sandoval, Claudio

“…Abdominal pain during cancer chemotherapy may be caused by medical or surgical conditions. A retrospective review of 5 children with cancer who had…”
Get full text

Impact of KIR/KIR ligand genotype for neuroblastoma patients in a phase III COG immunotherapy trial by Erbe, Amy K, Wang, Wei, Carmichael, Lakeesha, Kim, KyungMann, Mendonca, Eneida A, Song, Yiqiang, Hess, Dustin, London, Wendy B., Hank, Jacquelyn A, Dicciani, Mitchell B, Reisfeld, Ralph A, Gillies, Stephen D, Hogarty, Michael D., Maris, John M., Park, Julie R., Ozkaynak, Mehmet Fevzi, Gilman, Andrew Lee, Yu, Alice L., Sondel, Paul M.

“…Abstract only…”
Get full text

A comprehensive safety trial of chimeric antibody 14.18 (ch14.18) with GM-CSF, IL-2, and isotretinoin in high-risk neuroblastoma patients following myeloablative therapy: A Children's Oncology Group study by Ozkaynak, Mehmet Fevzi, Gilman, Andrew Lee, Yu, Alice L., London, Wendy B., Sondel, Paul M, Smith, Malcolm A., Seeger, Robert, Reynolds, C. Patrick, Maris, John M., Park, Julie R.

“…Abstract only…”
Get full text

Low day 100 transplant-related mortality (TRM) and relapse rate following clofarabine (CLO) in combination with cytarabine, total body irradiation (TBI), and allogeneic stem cell transplantation (AlloSCT) in children, adolescents, and young adults (CAYA) with poor-risk acute leukemia by Radhakrishnan, Kavita, Ricci, Angela M, Geyer, Mark B, Harrison, Lauren, Duffy, Deirdre, Ozkaynak, Mehmet Fevzi, Satwani, Prakash, Cheerva, Alexandra C, Talano, Julie, Moore, Theodore, Gillio, Alfred P, Wada, Randal K., Baxter-Lowe, Lee Ann, Cairo, Mitchell S.

“…Abstract only 6537 Background: CAYA with ALL or AML in third complete remission (CR3), refractory relapse (RR) or induction failure (IF) have an extremely poor…”
Get full text